Transfusion medicine

  • Clinical transfusion medicine
  • Modern approach to transfusion medicine immunology
  • Aspects of safety in blood donation and haemotherapy
  • Unconventional use of blood components


  • Plasma-related hemorrhagic diathesis
  • Platelet-related hemorrhagic diathesis
  • How to diagnose and treat genetic haemostasis disorders
  • Venous thromboembolism (VTE)

Myeloproliferative disease

  • Acute myeloid leukaemia
  • Myelodysplastic syndromes - present and future
  • Chronic myeloid leukaemia - reflection of progress in haematologic oncology
  • Philadelphia-negative myeloproliferative neoplasms
  • Rare myeloproliferative neoplasms


  • Chronic lymphocytic leukemia
  • Aggressive lymphomas
  • T-cell non Hodgkin's lymphomas
  • Central nervous system lymphomas
  • Hodgkin lymphoma
  • Acute lymphoblastic leukaemia in children and adults
  • Plasma cell myeloma
  • Plasma cell dyscrasias


  • Anaemias
  • Marrow aplasias and paroxysmal nocturnal hemoglobinuria


  • Autologous hematopoietic stem cell transplants
  • Autologous hematopoietic stem cell transplants
  • Immunological disorders in transplantation medicine and in other branches of medicine

Supportive treatment

  • Vaccinations and infection prevention
  • Thrombotic complications in hematologic oncology


  • Polish Cancer Patient Coalition
  • Experimental haematology
  • Pre-clinical haematology
  • Cytogenetic and molecular studies in haematologic oncology
  • Molecular hematology. From research through modern diagnostics to novel treatment
  • Flow cytometry in haematological diagnostics
  • Marginal lymphomas in WHO 2016 classification - a perspective of a haematopathologist
  • Laboratory diagnostics in haemostasis
  • CAR-T therapy